Comparative study on salivary IL- 8 and LDH among tobacco users without lesions, leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. [PDF]
Venkatesh S, K SG, Ganesan N.
europepmc +1 more source
Serum iron, zinc and copper among Indian patients with leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. [PDF]
Kavle P +7 more
europepmc +1 more source
Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis. [PDF]
Yasothkumar D +4 more
europepmc +1 more source
Immune suppression, HLA-risk and potential future immune based targets of oral leukoplakia progression. [PDF]
Soni M +4 more
europepmc +1 more source
Leukoplakia of oral cavity and urinary bladder are premalignant to squamous carcinoma. [PDF]
Wishahi M.
europepmc +1 more source
Descriptive transcriptomic profiling differentiates oral leukoplakia from proliferative verrucous leukoplakia and reveals distinct molecular signatures. [PDF]
Pérez-Sayáns M +11 more
europepmc +1 more source
Role of Stem Cells and Stem Cell Markers in Oral Potentially Malignant Disorders and Malignant Transformation: A Systematic Review. [PDF]
Piyarathne NS +4 more
europepmc +1 more source
Proliferative verrucous leukoplakia management requires x-ray surveillance. A retrospective study of 78 cases. [PDF]
Molnarova N +7 more
europepmc +1 more source
Upregulation of Derlin 3 (DERL3) protein expression is associated with Oral Cancer progression and is independent of promoter hypermethylation. [PDF]
Inchanalkar M +5 more
europepmc +1 more source

